Humana Inc. (HUM)
NYSE · Healthcare · Medical - Healthcare Plans
Profile
Humana Inc.
- Exchange
- NYSE
- Ticker
- HUM
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Country
- US
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Key facts
Humana Inc.: key facts
- Humana Inc. (NYSE: HUM) is a Medical - Healthcare Plans company in the Healthcare sector.
- In fiscal 2025, Humana Inc. reported revenue of $129.7B and net income of $1.2B.
- Revenue grew 11.6% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $145.7B and net income was $1.3B.
MonkScore
Humana Inc.'s MonkScore
MonkScore
MonkScore range: 50–60
as of October 2026
Sector rank: 322 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth50–60
- Profitability60–70
- Quality30–40
- Market Conviction30–40
- Safety40–50
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Humana Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $145.7B | $129.7B | $117.8B | $106.4B | $92.9B | $83.6B |
| Gross profit | $19.9B | $18.9B | $17.1B | $18.0B | $17.2B | $14.4B |
| Operating income | $2.0B | $1.5B | $1.6B | $3.3B | $3.6B | $3.4B |
| Net income | $1.3B | $1.2B | $1.2B | $2.5B | $2.8B | $2.9B |
| Operating cash flow | $147.0M | $921.0M | $3.0B | $4.0B | $4.6B | $2.3B |
| Capital expenditure | -$590.0M | -$546.0M | -$575.0M | -$1.0B | -$1.1B | -$1.3B |
| Free cash flow | -$443.0M | $375.0M | $2.4B | $3.0B | $3.5B | $920.0M |
| Total debt | $14.2B | $12.9B | $12.3B | $12.3B | $11.8B | $13.2B |
| Cash | $6.9B | $4.2B | $2.2B | $4.7B | $5.1B | $3.4B |
Revenue growth a year
- 1-year
- 10.1%
- 3-year
- 11.7%
- 4-year
- 11.6%
Compound growth between fiscal years.
Peers
Similar companies
- Clover Health Investments, Corp.NASDAQ:CLOVMonkScore range: 60–70
- UnitedHealth Group IncorporatedNYSE:UNHMonkScore range: 60–70
- Oscar Health, Inc.NYSE:OSCRMonkScore range: 80–90
- Progyny, Inc.NASDAQ:PGNYMonkScore range: 90–100
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.